This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2828) Pulmonology, COPD (168) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1579) mHealth for Treatment Adherence (437)

Published on in Vol 3, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13286, first published .
Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Authors of this article:

Jessica Chen1 Author Orcid Image ;   Leanne Kaye2 Author Orcid Image ;   Michael Tuffli2 Author Orcid Image ;   Meredith A Barrett2 Author Orcid Image ;   Shelanda Jones-Ford3 Author Orcid Image ;   Tina Shenouda3 Author Orcid Image ;   Rahul Gondalia2 Author Orcid Image ;   Kelly Henderson2 Author Orcid Image ;   Veronica Combs4 Author Orcid Image ;   David Van Sickle5 Author Orcid Image ;   David A Stempel2 Author Orcid Image
Article Authors Cited by (18) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
JMIR Publications JMIR Publications @jmirpub

JMIR Formative Res: Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chron… https://t.co/CYKtbtprm1

1:40 PM · Oct 23, 2019

2
1
Rahul G. Rahul G. @rahgonda

RT @jmirpub: JMIR Formative Res: Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstruct…

5:21 PM · Oct 23, 2019

2
1
S. Farmacia Gregorio S. Farmacia Gregorio @farma_gregorio

La monitorización ???? de pacientes con EPOC mediante mHealth ???? consigue reducir el uso de betaagonistas de acción cor… https://t.co/r6sJtNiceW

7:55 PM · Jan 27, 2020

2
0